3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
Structure Info
- Chemspace ID
- CSSB06744500023 (In-Stock Building Blocks)
- CAS
- 14656-93-0, 329222-74-4
- MFCD
- MFCD34641781
- IUPAC Name
- 3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione
- Mol formula
- C17H12N2O4
- Mol weight
- 308 Da
- Catalog Number(s)
- ArZ-UP415740, EN300-33336997, HTS065245, ST0294MD, TX0294B9, Z1269641791, ZX-NM281264
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.01
- Heavy atoms count
- 23
- Rotatable bond count
- 1
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.176
- Polar surface area (Å)
- 84
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione (C17H12N2O4) - CSSB06744500023](/st/structure/200/d71651813c7115e719539f57ee07767c/O%253DC1CCC%2528N2C%2528%253DO%2529c3cccc4cccc%2528C2%253DO%2529c34%2529C%2528%253DO%2529N1.png "C17H12N2O4")
- Zoom the structure
- CSSB06744500023
Items Overall 5 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 118.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 176.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 252.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 457.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 584.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 8-amino-3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744473434](/st/structure/200/ca1c9e301f6d24b75bb0a6a5c8e07aa6/Nc1ccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc1c23.png)
![Chemical structure of 7-amino-3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744473716](/st/structure/200/b4ed55e93754429139dda514ad3c1cda/Nc1cc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc%2528c1%2529c23.png)
![Chemical structure of 7-amino-3-[(3S)-2,6-dioxopiperidin-3-yl]-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB21511091586](/st/structure/200/2d6a8422c85c5ef022c5424f017bc34b/NC1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528%255BC%2540H%255D1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-7-hydroxy-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB03437847384](/st/structure/200/e0188638ef7df14a125803331426d2bd/OC1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
![Chemical structure of 8-bromo-3-(2,6-dioxopiperidin-3-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744473435](/st/structure/200/970e5a5270ba9fe2a9899cc6ca042ef9/Brc1ccc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc1c23.png)
![Chemical structure of [3-(2,6-dioxopiperidin-3-yl)-2,4-dioxo-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-7-yl]boronic acid - CSSB14948340480](/st/structure/200/1dc37d1287ea0095b22f4189868c20f7/OB%2528O%2529C1%253DCC2%253DCC%253DCC3%253DC2C%2528%253DC1%2529C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C3%253DO.png)
![Chemical structure of 2-{[3-(2,6-dioxopiperidin-3-yl)-2,4-dioxo-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-7-yl]amino}acetic acid hydrochloride - CSSB06835394598](/st/structure/200/3e2d58941125644f9c09c28ab98df772/Cl.OC%2528%253DO%2529CNc1cc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc%2528c1%2529c23.png)
![Chemical structure of 3-(2,6-dioxopiperidin-3-yl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione - CSSB06744473684](/st/structure/200/f68e80d518c3b7de62b195be8df56068/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c1cc2C%2528%253DO%2529N%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c3cccc%2528c1%2529c23.png)
Similarity Analogs
![Chemical structure of 2-[(3S)-2,6-dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione - CSSB00015459503](/st/structure/200/438b1e6de1ab3eac15ccb378c1d9c853/O%253DC1N%2528%255BC%2540H%255D2CCC%2528%253DO%2529NC2%253DO%2529C%2528%253DO%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of 2-[(3R)-2,6-dioxopiperidin-3-yl]-2,3-dihydro-1H-isoindole-1,3-dione - CSSB00015459504](/st/structure/200/7d8efe59c08f5f2141609e6a90fe5ce5/O%253DC1N%2528%255BC%2540%2540H%255D2CCC%2528%253DO%2529NC2%253DO%2529C%2528%253DO%2529C2%253DCC%253DCC%253DC12.png)
